Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7.
about
Anti-biofilm Activity as a Health IssueIntra- and inter-species interactions within biofilms of important foodborne bacterial pathogensAntibiofilm polysaccharidesMasquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesPromising biotechnological applications of antibiofilm exopolysaccharides.Antibiofilm activity of Actinobacillus pleuropneumoniae serotype 5 capsular polysaccharideAnti-biofilm activity: a function of Klebsiella pneumoniae capsular polysaccharideEscherichia coli O157:H7-Clinical aspects and novel treatment approaches.Antibiofilm and antibacterial effects of specific chitosan molecules on Staphylococcus aureus isolates associated with bovine mastitis.Indole-3-acetaldehyde from Rhodococcus sp. BFI 332 inhibits Escherichia coli O157:H7 biofilm formation.Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide.Probiotics to counteract biofilm-associated infections: promising and conflicting dataExopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice.Anti-biofilm activity of an exopolysaccharide from a sponge-associated strain of Bacillus licheniformis.Exopolysaccharide Produced by Lactobacillus Plantarum Induces Maturation of Dendritic Cells in BALB/c Mice.In Vitro Antibiofilm Activity of an Exopolysaccharide from the Marine Thermophilic Bacillus licheniformis T14.Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responses.Lactobacillus rhamnosus GR-1 Ameliorates Escherichia coli-Induced Inflammation and Cell Damage via Attenuation of ASC-Independent NLRP3 Inflammasome ActivationEffects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice.Evidence for broad-spectrum biofilm inhibition by the bacterium Bacillus sp. strain SW9.Dioxins: diagnostic and prognostic challenges arising from complex mechanismsMulti-species biofilms: how to avoid unfriendly neighbors.Extracellular molecular effectors mediating probiotic attributes.The Use of Lactic Acid Bacteria Starter Culture in the Production of Nunu, a Spontaneously Fermented Milk Product in Ghana.Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans.Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.Production, purification, and antibiofilm activity of a novel exopolysaccharide from Arthrobacter sp. B4.Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.Effect of bacteriocin and exopolysaccharides isolated from probiotic on P. aeruginosa PAO1 biofilm.Microbiological aspects of the biofilm on wooden utensils used to make a Brazilian artisanal cheese.Possible involvement of Mycoplasma hominis in inhibiting the formation of biofilms by uropathogenic Escherichia coli (UPEC).Microbial Competition of Rhodotorula mucilaginosa UANL-001L and E. coli increase biosynthesis of Non-Toxic Exopolysaccharide with Applications as a Wide-Spectrum Antimicrobial.EPSP of L. casei BL23 Protected against the Infection Caused by Aeromonas veronii via Enhancement of Immune Response in Zebrafish.Probiotic-mediated competition, exclusion and displacement in biofilm formation by food-borne pathogens.Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp.Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli.
P2860
Q26747450-549FC948-9A71-49F1-AA58-805C774E1C3DQ26782821-CCBF17E3-C3D5-4015-ADBA-741DED908D75Q26830763-B3621D57-D11C-449B-9BB9-0D65F15CFABBQ26865784-45D4B69C-24C8-4F35-B25A-E192D99E0D5CQ27686972-F82A4D5C-3C6D-4D6B-A186-06EE790515D6Q28487976-302D87D0-19AE-4473-92D1-65FB1CA7FA42Q28539739-376AC180-1F4E-4A80-A2A8-33FD698A4AB3Q33404448-63B3EEDB-4B8E-427A-89D2-DC1D69D75C49Q33653226-9F979C1F-F102-4D62-B2DF-7A86C484FAE8Q34139508-C7D16A98-A0CB-4890-9058-ABC381800AB9Q35139209-63528F33-1465-4D62-BDC8-B448C9720FF0Q35278680-FC9446E9-815A-462B-998C-AE152E9C1BF0Q35336070-E535CE12-E71C-417E-838F-57BAD7798A14Q35389824-19669FA5-DD69-4593-BE12-1D9FED31147DQ35850272-5CB7CE2B-9129-42AE-B114-7C5859466386Q35889729-2E47DA51-46A7-4AE1-81D3-318562753421Q36155996-8B4905CD-EA12-44AD-B1C7-B22F0A35CA70Q36575117-D9A0DF6B-5E9B-4248-B4F4-B5A8CEC65612Q36575435-920DFA21-3848-4493-B27D-FA8F59F97D4FQ36667304-F3D277B4-0268-49DF-B10A-27C45D5DF39FQ37255560-FC67E2D0-4E56-4C29-9D93-EA1B2849BCFEQ37978400-9D0BD7E0-B56F-47A3-A792-AB68FE7FB172Q38239242-632CC3B9-DFF7-45AD-8D53-5789DA5DFDCBQ38284388-F273A73C-7A32-469E-B7BC-98E2C65E39C6Q38850783-A5E91ABE-C811-4607-9EED-2CFA74990F2FQ38995452-D2FD437C-DA1B-4ABF-B895-A1FA98419924Q39210862-0EFB046D-F2BD-4FD1-A28A-42FDF14CF622Q39220650-5C04AE36-729B-4AC6-8F39-8FE0891CF7EDQ39458640-FF1E65D6-0285-496B-802F-3D1EFF67D9CBQ40047173-3C7D74DB-CA4A-470B-9EF9-FD7D6CD08AB1Q42883544-2AB35380-0DB9-4CD0-97E6-415CE2A4CEB7Q46986718-4055341C-E514-4176-9CFB-558A61E51068Q48240065-E36F2483-9CCA-4DCA-9BA9-6B8BA1BCCC3DQ49419578-9F262B4D-D632-4427-84F7-EE760E066EC4Q50019022-D2B63E56-C765-4CB2-B510-A961D86EE785Q53685610-35E3E9EF-05DE-4D78-ADBD-95CAC561F2C4Q55510223-47A3FE8C-30EE-4AB9-8960-EFA161A9CD7E
P2860
Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Released exopolysaccharide (r- ...... agic Escherichia coli O157:H7.
@en
Released exopolysaccharide
@nl
type
label
Released exopolysaccharide (r- ...... agic Escherichia coli O157:H7.
@en
Released exopolysaccharide
@nl
prefLabel
Released exopolysaccharide (r- ...... agic Escherichia coli O157:H7.
@en
Released exopolysaccharide
@nl
P2093
P921
P1476
Released exopolysaccharide (r- ...... agic Escherichia coli O157:H7.
@en
P2093
Sae Hun Kim
Younghoon Kim
P304
P356
10.1016/J.BBRC.2008.12.053
P577
2008-12-25T00:00:00Z